{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T11:01:37Z","timestamp":1786446097975,"version":"build-2736575974"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T00:00:00Z","timestamp":1717459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Natural Science Foundation of Guangdong Province, China","award":["2022A1515010472"],"award-info":[{"award-number":["2022A1515010472"]}]},{"name":"the Natural Science Foundation of Guangdong Province, China","award":["2022A1515010472"],"award-info":[{"award-number":["2022A1515010472"]}]},{"name":"the Natural Science Foundation of Guangdong Province, China","award":["2022A1515010472"],"award-info":[{"award-number":["2022A1515010472"]}]},{"name":"the Natural Science Foundation of Guangdong Province, China","award":["2022A1515010472"],"award-info":[{"award-number":["2022A1515010472"]}]},{"name":"the Natural Science Foundation of Guangdong Province, China","award":["2022A1515010472"],"award-info":[{"award-number":["2022A1515010472"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"DOI":"10.1007\/s00330-024-10821-5","type":"journal-article","created":{"date-parts":[[2024,6,4]],"date-time":"2024-06-04T19:04:04Z","timestamp":1717527844000},"page":"7233-7243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The diagnostic value of [18F]FAPI-42 PET\/CT for pulmonary artery masses: comparison with [18F]FDG PET\/CT"],"prefix":"10.1007","volume":"34","author":[{"given":"Peng","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixiang","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenliang","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youcai","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huizhen","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimin","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jielong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jilong","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1997-5687","authenticated-orcid":false,"given":"Xinlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,4]]},"reference":[{"key":"10821_CR1","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.21037\/jtd.2016.08.89","volume":"8","author":"D Bandyopadhyay","year":"2016","unstructured":"Bandyopadhyay D, Panchabhai TS, Bajaj NS et al (2016) Primary pulmonary artery sarcoma: a close associate of pulmonary embolism\u201420-year observational analysis. J Thorac Dis 8:2592\u20132601. https:\/\/doi.org\/10.21037\/jtd.2016.08.89","journal-title":"J Thorac Dis"},{"key":"10821_CR2","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s12149-009-0292-y","volume":"23","author":"K Ito","year":"2009","unstructured":"Ito K, Kubota K, Morooka M et al (2009) Diagnostic usefulness of 18F-FDG PET\/CT in the differentiation of pulmonary artery sarcoma and pulmonary embolism. Ann Nucl Med 23:671\u2013676. https:\/\/doi.org\/10.1007\/s12149-009-0292-y","journal-title":"Ann Nucl Med"},{"key":"10821_CR3","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1445-2197.2012.06205.x","volume":"83","author":"EJ Lee","year":"2012","unstructured":"Lee EJ, Moon SH, Choi JY et al (2012) Usefulness of fluorodeoxyglucose positron emission tomography in malignancy of pulmonary artery mimicking pulmonary embolism. ANZ J Surg 83:342\u2013347. https:\/\/doi.org\/10.1111\/j.1445-2197.2012.06205.x","journal-title":"ANZ J Surg"},{"key":"10821_CR4","doi-asserted-by":"publisher","first-page":"4109","DOI":"10.1007\/s00259-022-05851-4","volume":"49","author":"C Hong","year":"2022","unstructured":"Hong C, Hou P, Chen H et al (2022) Improving the imaging diagnostic strategy for pulmonary artery masses based on 18F-FDG PET\/CT integrated with CTPA. Eur J Nucl Med Mol Imaging 49:4109\u20134121. https:\/\/doi.org\/10.1007\/s00259-022-05851-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10821_CR5","doi-asserted-by":"publisher","first-page":"1519","DOI":"10.21873\/invivo.12861","volume":"36","author":"H Suto","year":"2022","unstructured":"Suto H, Suto M, Inui Y, Okamura A (2022) Difficulty in distinguishing pulmonary arterial intimal sarcoma from pulmonary thromboembolism using FDG PET\/CT. In Vivo 36:1519\u20131522. https:\/\/doi.org\/10.21873\/invivo.12861","journal-title":"In Vivo"},{"key":"10821_CR6","doi-asserted-by":"publisher","first-page":"e127","DOI":"10.1097\/rlu.0000000000003376","volume":"46","author":"JJ Rosales Castillo","year":"2020","unstructured":"Rosales Castillo JJ, Garc\u00eda L, Bastidas JF et al (2020) Pulmonary artery sarcoma with low 18F-FDG uptake. Clin Nucl Med 46:e127\u2013e128. https:\/\/doi.org\/10.1097\/rlu.0000000000003376","journal-title":"Clin Nucl Med"},{"key":"10821_CR7","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-8-40","volume":"8","author":"D-H Lee","year":"2013","unstructured":"Lee D-H, Jung T-E, Lee J-H et al (2013) Pulmonary artery intimal sarcoma: poor 18F-fluorodeoxyglucose uptake in positron emission computed tomography. J Cardiothorac Surg 8:40. https:\/\/doi.org\/10.1186\/1749-8090-8-40","journal-title":"J Cardiothorac Surg"},{"key":"10821_CR8","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s00392-012-0425-5","volume":"101","author":"M Hoiczyk","year":"2012","unstructured":"Hoiczyk M, Iliodromitis K, Bauer S et al (2012) Intimal sarcoma of the pulmonary artery with unusual findings: a case report. Clin Res Cardiol 101:397\u2013401. https:\/\/doi.org\/10.1007\/s00392-012-0425-5","journal-title":"Clin Res Cardiol"},{"key":"10821_CR9","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1007\/s10554-021-02208-0","volume":"37","author":"W Nie","year":"2021","unstructured":"Nie W, Gao L, Du Y, Yuan X (2021) Pulmonary artery fungal infection with imaging findings resembling pulmonary artery sarcoma. Int J Cardiovasc Imaging 37:2323\u20132325. https:\/\/doi.org\/10.1007\/s10554-021-02208-0","journal-title":"Int J Cardiovasc Imaging"},{"key":"10821_CR10","doi-asserted-by":"publisher","first-page":"e129","DOI":"10.1097\/rlu.0000000000003355","volume":"46","author":"Abdulrahman Masrani","year":"2020","unstructured":"Abdulrahman Masrani, Raptis DA, Siegel BA (2020) Sarcoidosis mimicking primary pulmonary artery sarcoma. Clin Nucl Med 46:e129\u2013e130. https:\/\/doi.org\/10.1097\/rlu.0000000000003355","journal-title":"Clin Nucl Med"},{"key":"10821_CR11","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1097\/rlu.0000000000002916","volume":"45","author":"G Hou","year":"2020","unstructured":"Hou G, Chen K, Jiang Y et al (2020) Rosai-Dorfman disease presenting as a pulmonary artery mass on FDG PET\/CT. Clin Nucl Med 45:392\u2013393. https:\/\/doi.org\/10.1097\/rlu.0000000000002916","journal-title":"Clin Nucl Med"},{"key":"10821_CR12","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1097\/rlu.0000000000004141","volume":"47","author":"A Dong","year":"2022","unstructured":"Dong A, Zhang Z, Yang Q et al (2022) 68Ga-FAPI-04 versus 18F-FDG PET\/CT in a case with intimal sarcoma of the pulmonary artery. Clin Nucl Med 47:748\u2013750. https:\/\/doi.org\/10.1097\/rlu.0000000000004141","journal-title":"Clin Nucl Med"},{"key":"10821_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.2967\/jnumed.119.227967","volume":"60","author":"C Kratochwil","year":"2019","unstructured":"Kratochwil C, Flechsig P, Lindner T et al (2019) 68Ga-FAPI PET\/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med 60:801\u2013805. https:\/\/doi.org\/10.2967\/jnumed.119.227967","journal-title":"J Nucl Med"},{"key":"10821_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1007\/s10555-020-09909-3","volume":"39","author":"AA Fitzgerald","year":"2020","unstructured":"Fitzgerald AA, Weiner LM (2020) The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev 39:783\u2013803. https:\/\/doi.org\/10.1007\/s10555-020-09909-3","journal-title":"Cancer Metastasis Rev"},{"key":"10821_CR15","doi-asserted-by":"publisher","first-page":"e0116683","DOI":"10.1371\/journal.pone.0116683","volume":"10","author":"F Liu","year":"2015","unstructured":"Liu F, Li Q, Liu B et al (2015) Fibroblast activation protein overexpression and clinical implications in solid tumors: a meta-analysis. PLoS One 10:e0116683\u2013e0116683. https:\/\/doi.org\/10.1371\/journal.pone.0116683","journal-title":"PLoS One"},{"key":"10821_CR16","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/j.1365-2559.2009.03399.x","volume":"55","author":"O Dohi","year":"2009","unstructured":"Dohi O, Ohtani H, Hatori M et al (2009) Histogenesis-specific expression of fibroblast activation protein and dipeptidylpeptidase-IV in human bone and soft tissue tumours. Histopathology 55:432\u2013440. https:\/\/doi.org\/10.1111\/j.1365-2559.2009.03399.x","journal-title":"Histopathology"},{"key":"10821_CR17","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/jso.23368","volume":"108","author":"D Yuan","year":"2013","unstructured":"Yuan D, Liu B, Liu K et al (2013) Overexpression of fibroblast activation protein and its clinical implications in patients with osteosarcoma. J Surg Oncol 108:157\u2013162. https:\/\/doi.org\/10.1002\/jso.23368","journal-title":"J Surg Oncol"},{"key":"10821_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2967\/jnumed.121.262096","volume":"63","author":"L Kessler","year":"2021","unstructured":"Kessler L, Ferdinandus J, Hirmas N et al (2021) 68Ga-FAPI as a diagnostic tool in sarcoma: data from the 68Ga-FAPI PET prospective observational trial. J Nucl Med 63:89\u201395. https:\/\/doi.org\/10.2967\/jnumed.121.262096","journal-title":"J Nucl Med"},{"key":"10821_CR19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1007\/s11307-021-01679-w","volume":"24","author":"Y Li","year":"2021","unstructured":"Li Y, Lin X, Li Y et al (2021) Clinical utility of F-18 labeled fibroblast activation protein inhibitor (FAPI) for primary staging in lung adenocarcinoma: a prospective study. Mol Imaging Biol 24:309\u2013320. https:\/\/doi.org\/10.1007\/s11307-021-01679-w","journal-title":"Mol Imaging Biol"},{"key":"10821_CR20","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1158\/1078-0432.ccr-06-1746","volume":"13","author":"LR Henry","year":"2007","unstructured":"Henry LR, Lee H-O, Lee JS et al (2007) Clinical implications of fibroblast activation protein in patients with colon cancer. Clin Cancer Res 13:1736\u20131741. https:\/\/doi.org\/10.1158\/1078-0432.ccr-06-1746","journal-title":"Clin Cancer Res"},{"key":"10821_CR21","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.canlet.2004.06.030","volume":"227","author":"S Iwasa","year":"2005","unstructured":"Iwasa S, Okada K, Chen W-T et al (2005) Increased expression of seprase, a membrane-type serine protease, is associated with lymph node metastasis in human colorectal cancer. Cancer Lett 227:229\u2013236. https:\/\/doi.org\/10.1016\/j.canlet.2004.06.030","journal-title":"Cancer Lett"},{"key":"10821_CR22","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/1097-0215(20010120)95:1<67::AID-IJC1012>3.0.CO;2-U","volume":"95","author":"N Ariga","year":"2001","unstructured":"Ariga N, Sato E, Ohuchi N et al (2001) Stromal expression of fibroblast activation protein\/seprase, a cell membrane serine proteinase and gelatinase, is associated with longer survival in patients with invasive ductal carcinoma of breast. Int J Cancer 95:67\u201372","journal-title":"Int J Cancer"},{"key":"10821_CR23","doi-asserted-by":"publisher","first-page":"1395","DOI":"10.1007\/s10554-019-01553-5","volume":"35","author":"X Xi","year":"2019","unstructured":"Xi X, Gao W, Gong J et al (2019) Value of 18F-FDG PET\/CT in differentiating malignancy of pulmonary artery from pulmonary thromboembolism: a cohort study and literature review. Int J Cardiovasc Imaging 35:1395\u20131403. https:\/\/doi.org\/10.1007\/s10554-019-01553-5","journal-title":"Int J Cardiovasc Imaging"},{"key":"10821_CR24","doi-asserted-by":"publisher","first-page":"3918","DOI":"10.1007\/s00259-021-05374-4","volume":"48","author":"SA Koerber","year":"2021","unstructured":"Koerber SA, Finck R, Dendl K et al (2021) Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET\/CT. Eur J Nucl Med Mol Imaging 48:3918\u20133924. https:\/\/doi.org\/10.1007\/s00259-021-05374-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10821_CR25","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1093\/eurheartj\/ehaa931","volume":"42","author":"L Zhao","year":"2020","unstructured":"Zhao L, Pang Y, Qi L, Chen H (2020) Cardiac angiosarcoma detected using 68Ga-fibroblast activation protein inhibitor positron emission tomography\/magnetic resonance. Eur Heart J 42:1276\u20131276. https:\/\/doi.org\/10.1093\/eurheartj\/ehaa931","journal-title":"Eur Heart J"},{"key":"10821_CR26","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1007\/s00259-022-05700-4","volume":"49","author":"B Gu","year":"2022","unstructured":"Gu B, Liu X, Wang S et al (2022) Head-to-head evaluation of [18F]FDG and [68 Ga]Ga-DOTA-FAPI-04 PET\/CT in recurrent soft tissue sarcoma. Eur J Nucl Med Mol Imaging 49:2889\u20132901. https:\/\/doi.org\/10.1007\/s00259-022-05700-4","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10821_CR27","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1053\/j.semnuclmed.2023.02.001","volume":"53","author":"M Bentestuen","year":"2023","unstructured":"Bentestuen M, Al-Obaydi N, Zacho HD (2023) FAPI-avid nonmalignant PET\/CT findings: an expedited systematic review. Semin Nucl Med 53:694\u2013705. https:\/\/doi.org\/10.1053\/j.semnuclmed.2023.02.001","journal-title":"Semin Nucl Med"},{"key":"10821_CR28","doi-asserted-by":"publisher","first-page":"1820","DOI":"10.1007\/s00259-020-04769-z","volume":"47","author":"H Chen","year":"2020","unstructured":"Chen H, Pang Y, Wu J et al (2020) Comparison of [68Ga]Ga-DOTA-FAPI-04 and [18F] FDG PET\/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820\u20131832. https:\/\/doi.org\/10.1007\/s00259-020-04769-z","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10821_CR29","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1148\/radiol.211424","volume":"303","author":"L Wang","year":"2022","unstructured":"Wang L, Tang G, Hu K et al (2022) Comparison of 68Ga-FAPI and 18F-FDG PET\/CT in the evaluation of advanced lung cancer. Radiology 303:191\u2013199. https:\/\/doi.org\/10.1148\/radiol.211424","journal-title":"Radiology"},{"key":"10821_CR30","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1007\/s00259-020-05070-9","volume":"48","author":"X Shi","year":"2020","unstructured":"Shi X, Xing H, Yang X et al (2020) Comparison of PET imaging of activated fibroblasts and 18F-FDG for diagnosis of primary hepatic tumours: a prospective pilot study. Eur J Nucl Med Mol Imaging 48:1593\u20131603. https:\/\/doi.org\/10.1007\/s00259-020-05070-9","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10821_CR31","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1007\/s00259-019-04444-y","volume":"46","author":"M R\u00f6hrich","year":"2019","unstructured":"R\u00f6hrich M, Loktev A, Wefers AK et al (2019) IDH-wildtype glioblastomas and grade III\/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein\u2013specific PET\/CT. Eur J Nucl Med Mol Imaging 46:2569\u20132580. https:\/\/doi.org\/10.1007\/s00259-019-04444-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10821_CR32","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00259-021-05423-y","volume":"49","author":"C Kesch","year":"2021","unstructured":"Kesch C, Yirga L, Dendl K et al (2021) High fibroblast-activation-protein expression in castration-resistant prostate cancer supports the use of FAPI-molecular theranostics. Eur J Nucl Med Mol Imaging 49:385\u2013389. https:\/\/doi.org\/10.1007\/s00259-021-05423-y","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10821_CR33","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.2967\/jnumed.121.262426","volume":"63","author":"CE Mona","year":"2021","unstructured":"Mona CE, Benz MR, Hikmat F et al (2021) Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study. J Nucl Med 63:1021\u20131026. https:\/\/doi.org\/10.2967\/jnumed.121.262426","journal-title":"J Nucl Med"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00330-024-10821-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-024-10821-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T15:10:16Z","timestamp":1730128216000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00330-024-10821-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,4]]},"references-count":33,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2024,11]]}},"alternative-id":["10821"],"URL":"https:\/\/doi.org\/10.1007\/s00330-024-10821-5","relation":{},"ISSN":["1432-1084"],"issn-type":[{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,4]]},"assertion":[{"value":"2 November 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The scientific guarantor of this publication is Xinlu Wang.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Guarantor"}},{"value":"The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"No complex statistical methods were necessary for this paper.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statistics and biometry"}},{"value":"Written informed consent was obtained from all subjects (patients) in this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The study was performed in line with the principles of the Declaration of Helsinki and approved by the institutional review board (GZGYHR-2020-107).","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Some study subjects or cohorts have been previously reported in Hong C, Hou P, Chen H, et al [].","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Study subjects or cohorts overlap"}},{"order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Methodology"}}]}}